Share on StockTwits

Bioquell plc (LON:BQE) was downgraded by investment analysts at N 1 Singer to a “hold” rating in a note issued to investors on Friday, Analyst Ratings.Net reports. They currently have a GBX 112 ($1.89) price target on the stock, down from their previous price target of GBX 157 ($2.64). N 1 Singer’s price target would indicate a potential upside of 5.16% from the stock’s previous close.

Shares of Bioquell plc (LON:BQE) traded up 0.47% on Friday, hitting GBX 106.50. The stock had a trading volume of 23,427 shares. Bioquell plc has a 52 week low of GBX 120.50 and a 52 week high of GBX 154.00. The stock’s 50-day moving average is GBX 124.9 and its 200-day moving average is GBX 135.1. The company’s market cap is £45.2 million.

BQE has been the subject of a number of other recent research reports. Analysts at N+1 Singer downgraded shares of Bioquell plc to a “hold” rating in a research note on Friday. They now have a GBX 112 ($1.89) price target on the stock, down previously from GBX 157 ($2.64). Separately, analysts at Investec reiterated a “hold” rating on shares of Bioquell plc in a research note on Thursday.

Bioquell PLC is a holding company. It is engaged in the principal activities of designing, manufacturing and supplying of bio-decontamination and containment equipment, related products and services to the healthcare, life sciences and defense industries, and testing, regulatory and compliance services to a range of companies, including the aerospace, telecoms and defense industries.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.